SCHEMBL6595452

SCHEMBL6595452

CCOC(=O)c1c(C)c2cc(OC(C)=O)ccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 2/20 0.56
MAPT P10636 5/20 0.46
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
HTT P42858 1/20 0.46
CCR2 P41597 6/20 0.45
KDM4E B2RXH2 3/20 0.43
ELANE P08246 1/20 0.41
HPGD P15428 1/20 0.41
ALDH1A1 P00352 2/20 0.41
PKM P14618 2/20 0.40
MEN1 O00255 1/20 0.40
RGS12 O14924 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782383 0.92 ABCB11 (0.56) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL6780153 0.90 ABCB11 (0.54) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL6599360 0.81 ABCB11 (0.77) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL7083258 0.80 ABCB11 (0.43) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL7082951 0.80 ABCB11 (0.43) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL7089748 0.77 GAA (0.41) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL6300631 0.76 CCR2 (0.52) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL6302584 0.76 CCR2 (0.62) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL5216231 0.76 ABCB11 (0.52) ABCB11MAPTLMNASMN1; SMN2GAA
SCHEMBL5213680 0.76 CCR2 (0.65) ABCB11MAPTLMNASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150952-B1 INDOLE DERIVATIVES AND THEIR USE AS MCP-1 RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2004-10-27 EP disclosed
US-6737435-B1 ANTIINFLAMMATORY AGENTS; MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) DISEASES ASTRAZENECA AB (SE) 2004-05-18 US disclosed
EP-1150952-A1 INDOLE DERIVATIVES AND THEIR USE AS MCP-1 RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-11-07 EP disclosed
WO-2000046196-A1 INDOLE DERIVATIVES AND THEIR USE AS MCP-1 ANTAGONISTS ASTRAZENECA AB (SE) 2000-08-10 WO disclosed